Rubix LS’s Accountability Written by Catherine Cole on March 31, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Understanding Priorities for the Use of Digital Health Technologies to Support Clinical Trials for Drug Development and Review – Carrie Northcott Written by Catherine Cole on March 28, 2023. Posted in Nocturnal Scratch. Continue reading
Understanding Priorities for the Use of Digital Health Technologies to Support Clinical Trials for Drug Development and Review – Jeremy Wyatt Written by Catherine Cole on March 28, 2023. Posted in Nocturnal Scratch. Continue reading
Understanding Priorities for the Use of Digital Health Technologies to Support Clinical Trials for Drug Development and Review – Steve Xu Written by Catherine Cole on March 28, 2023. Posted in Nocturnal Scratch. Continue reading
V3 framework usage at Byteflies – Benjamin Vandendriessche Written by Catherine Cole on March 14, 2023. Posted in V3. Continue reading
GSK’s Inclusive Engagement Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Acclinate’s Inclusive Engagement Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Rubix LS’s Real World Data / Real World Evidence Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Sage Bionetworks’s Elements of a Digitized Clinical Trial Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Rubix LS’s Elements of a Digitized Clinical Trial Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Reveles’s Elements of a Digitized Clinical Trial Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
Lightship’s Elements of a Digitized Clinical Trial Written by Catherine Cole on March 9, 2023. Posted in DEI, DEI, Project, Resources. Continue reading
